QUOTE AND NEWS
Benzinga  Apr 22  Comment 
Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced data evaluating an...
Motley Fool  Mar 8  Comment 
It appears the biotech is experiencing the old sell-the-news decline.
Benzinga  Feb 22  Comment 
Genetic Technologies Limited (NASDAQ: GENE) is pleased to announce a partnership with international race car driver Ms. Pippa Mann to promote BREVAGenplus®, the Company's first-in-class, clinically validated risk assessment test for sporadic...
GenEng News  Feb 17  Comment 
Applied Genetic Technologies Corporation (AGTC), said today it has opened a new combined-use corporate office and laboratory in Alachua, FL. AGTC's new facility, within a multi-tenant site, consists of approximately 20,000 square feet that...
Benzinga  Feb 5  Comment 
Molecular diagnostics company Genetic Technologies Limited (NASDAQ: GENE) reports to have executed a Settlement and Release Agreement with Hendrix Genetics B.V. (Hendrix), of Boxmeer, The Netherlands. Following the execution of this Agreement,...
Benzinga  Dec 21  Comment 
Molecular diagnostics company Genetic Technologies Limited (NASDAQ: GENE) ("Company") announced today the publication of a new independent study in support of the BREVAGenplus® breast cancer risk assessment test for Caucasian women. The results...
Benzinga  Nov 2  Comment 
Phenogen Sciences, Inc., the U.S. subsidiary of Australia-based Genetic Technologies Limited (NASDAQ: GENE) and maker of BREVAGenplus, today commented on the American Cancer Society's (ACS) recent changes to its breast cancer screening guidelines....





You may also be interested in articles related to GENETIC TECHNOLOGIES (GENE):
 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki